Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
3
×
clinical trials
fda
3
×
life sciences
national blog main
national top stories
opioid
3
×
boulder/denver blog main
boulder/denver top stories
cancer
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
vertex pharmaceuticals
wisconsin blog main
wisconsin top stories
abbvie
acute myeloid leukemia
alkermes
allergan
What
ahead
asco
drug
fda
roundup
alkermes
ambien
american
annual
antipsychotic
attendees
attention
benefits
bio
biotech
branded
camp’s
cancer
cash
caveats
chicago
choices
city
clinical
combinations
commissioner
commonly
community’s
consumers
costly
counterweight
days
designed
drugs
effect
elevatebio
expanding
favor
focus
gain
Language
unset
Current search:
opioid
×
fda
×
" boston top stories "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More